RELATED CONTENT
NEWS
- NICE no for Novartis' Lucentis is good news for Allergan's Ozurdex
- SMC vetoes Sanofi's Jevtana, AZ's Vimovo and Merck's Emend, but OKs Simponi again
- Scotland says yes to Eliquis and Incivo but declines Ozurdex and Xgeva
- Allergan's Ozurdex to go eye-to-eye with Lucentis for BRVO
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

